Fellow

Back to directory listing

Dr. Sohaila Rastan FMedSci

Institution
Retired
Year elected
2001

Interests

Specialities

mouse genetics and developmental biology, drug discovery in big pharma and biotech, research management, third sector

Section committee elected by

Cellular and developmental biology, microbiology and immunology, genetics

Dr Sohaila Rastan is President and Chief Executive Officer at Ceros Limited. She has made a major impact on our understanding of X inactivation. This phenomenon was first described by Mary Lyon in the 1960’s at Harwell, where Sohaila Rastan subsequently undertook her PhD under Mary Lyon’s supervision. During this period Sohaila generated evidence that X chromosome inactivation was under the control of a single inactivation centre. She followed up this work by mapping, cloning and characterising the mouse Xist gene and proving functionally that it is the X inactivation centre. Her characterisation of the gene revealed it to be very unusual with no open reading frame, its product consisting of mRNA transcripts.

 
 
 
 
 
 
FB Twitter Instagram Youtube